Clinical Outcomes By Prior Oac Use And Switching To Edoxaban In Atrial Fibrillation 2 Year Follow Up Data

Clinical outcomes by prior OAC use and switching to edoxaban in atrial fibrillation: 2-year follow-up data 83616 from the ETNA-AF China study Hesong Zeng1,*, Changqian Wang2,*, Xianjin Li3, Jing Zhou4, Xinchun Yang5, Yajuan Liu6, Tiebi Tong7, Guanmin Tang8,... More

Clinical outcomes by prior OAC use and switching to edoxaban in atrial fibrillation: 2-year follow-up data 83616 from the ETNA-AF China study Hesong Zeng1,*, Changqian Wang2,*, Xianjin Li3, Jing Zhou4, Xinchun Yang5, Yajuan Liu6, Tiebi Tong7, Guanmin Tang8, Jian Liu9, Meise Lin10, Jiefu Yang11, Na Guo12, Yuan Yi12, Mengqi Liu12, Changsheng Ma13 1 Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China. 2Department of Cardiology, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. 3Department of Cardiology, Xuzhou Central Hospital, Xuzhou, China. 4Department of Cardiology, Peking University First Hospital, Beijing, China. 5 Department of Cardiology, Beijing Chao-Yang Hospital Capital Medical University, Beijing, China. 6Department of Cardiology, Beijing Miyun District Hospital, Beijing, China. 7Cardiac Center, China Shenyang Chest Hospital, Shenyang, Chin Less